170 - When introucing a new drug can we put the Health Canada classification, i.e. Angiotensin II receptor blocker or angiotensin receptor blocker of the drug on the same page as clinical information.


  • It is possible for the Health Canada pharmacological classification and claims within the limitations of the Terms of Market Authorization to appear on a single page. However, to avoid according clinical significance to the pharmacological classification, the claims will need to be presented such that they are separate and distinct messages. Call the PAAB office if you have any questions.